Can I use a supplement notification to prove CBD isolate authorization?

No. GIS guidance indicates that a supplement notification is not novel-food authorization, and isolate permission cannot be inferred from hemp seed products.

Does the 2021 GIS warning establish a current THC limit for all isolate?

No. The January 2021 warning is a historical enforcement example rather than a current national limit for all isolate.

European Union

Sources reviewed October 24, 2026

Poland CBD-Isolate Sourcing and Regulatory Compliance Guide

A guide for sourcing CBD isolate in Poland, focusing on GIS guidance regarding supplement notifications, medicinal claims, and historical THC enforcement.

Questions to verify, not legal advice

These guides summarize official sources and the questions a buyer should raise. Inclusion of a country is not a promise to supply it and does not mean CBD isolate may be sold there. Confirm current requirements with your regulatory or legal adviser.

The short answer

In Poland, the primary focus for CBD isolate procurement is the distinction between food supplements and medicinal products, as clarified by the Chief Sanitary Inspectorate (GIS) in September 2025. A supplement notification does not equate to novel-food authorization, and isolate must be handled as a distinct entity from traditional hemp seed products.

Regulatory Context for Poland

Polish market participants are advised to distinguish between food supplements and medicines. GIS has warned against presenting food as medicinal, emphasizing that marketing claims must remain separate from analytical test results.

GIS published a January 2021 warning concerning CBD oil with unauthorized extracts and THC levels, serving as a historical enforcement reference.
September 2025 GIS guidance explicitly separates supplements from medicinal products.

Procurement and Documentation

Buyers should ensure that technical documentation matches local requirements. It is essential to maintain the integrity of the original Certificate of Analysis (COA) while ensuring that translated sales descriptions do not introduce unverified claims.

Ask whether the proposed food ingredient and intended use have a valid authorization basis.
Check Polish labels and sales descriptions for medicinal claims separately from analytical results.
Require consistent units, lot references and reporting limits across translated documents.

Practical Procurement Inquiries

Prospective buyers are encouraged to clarify specific technical and operational details directly with suppliers to ensure compliance with Polish standards.

What are the specific method units and limits of detection for batch COAs?
Can the supplier provide verifiable documentation regarding the material origin?
Are quotes provided conditional on local destination permissions and importer roles?

Supplier Assessment Considerations

Beyond regulatory hurdles, managing the logistics of sampling and packaging requires a disciplined approach to ensure the final product meets the buyer's specification within Poland.

Define clear sampling criteria for incoming batches.
Confirm that packaging and written terms are consistent with the intended Polish market use.

Buyer questions

Can I use a supplement notification to prove CBD isolate authorization?: No. GIS guidance indicates that a supplement notification is not novel-food authorization, and isolate permission cannot be inferred from hemp seed products.
Does the 2021 GIS warning establish a current THC limit for all isolate?: No. The January 2021 warning is a historical enforcement example rather than a current national limit for all isolate.

Sources and context

Sources may be in the national language. Check the current version before relying on them.

Planning to buy CBD isolate for Poland?

Start an inquiry with this destination market filled in. If your draft already names a market, you will be asked before it changes.

Start an inquiry for Poland